Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 6 August 2008, doi:10.1136/bmj.a1138
Cite this as: BMJ 2008;337:a1138
| The first 150 words of the full text of this article appear below. |
We found the data reported by Langan et al on the apparent increasing incidence of pemphigoid striking.1
It might reasonably be expected that a fivefold increase in incidence of pemphigoid would be apparent to physicians caring for patients with the disorder. Blistering disorders are perhaps unusual among skin conditions in that they are nearly always reported to dermatologists, and specialised testing is required to establish the diagnosis. A straw poll among dermatological colleagues last week did not support the view that pemphigoid had been seen more often, and to examine this further we reviewed the incidence of positive tissue diagnoses of pemphigoid in our laboratory over the period 1994-2004. Such diagnostic biopsies tend to be taken only once, and generally at the onset of the disease. They therefore represent a surrogate marker of incidence of the condition.
Currently we receive over 2000 samples annually, and in the period 1994-2003 (for
Richard W Groves, head, clinical immunodermatology1, Balbir Bhogal, chief biomedical scientist1, Kathy Taghipour, research fellow1, Paola Caposciutti, research fellow1, Monika Saha, research fellow1
1 St Johns Institute of Dermatology, St Thomas Hospital, London SE1 7EH
richard.groves@kcl.ac.uk